IPO nets $417mm for 10x Genomics
Life science technology company 10x Genomics Inc. netted $417.1mm in its initial public offering of 11.5mm Class A common shares (including the overallotment) at $39. The company originally intended to sell 9mm shares between $31-35, later upped to a $36-38 range.
- Research, Analytical Equipment & Supplies
Drug Discovery Tools
- Drug Discovery Tools
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com